BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Teijin Limited Develops Plant-Based Biodegradable Adhesion Prevention Gel New Solution for Laparoscopic Surgery


9/19/2013 9:23:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Tokyo, Japan, September 19, 2013 --- Teijin Limited announced today that it has developed an adhesion prevention gel made with a plant-based biodegradable polymer that is expected to be effectively applied to laparoscopic surgery. The company plans to commercialize the material by 2020.

Teijin’s newly developed gel-form polysaccharide polymer is derived from chemically modified cellulose. As a gel, it can easily be used in narrow fields or on body parts with complex shapes, and as a plant-based biodegradable polymer, it is simply absorbed by the body after a few days with no need for surgical removal. Animal testing has already shown it to be effective in preventing adhesion.

Teijin is concurrently developing instruments specially designed for use in laparoscopic surgery, with this gel positioned as an optimal companion product.

Adhesions are fibrous bands that can grow between normally unconnected tissues after surgery, resulting in pain and serious postoperative complications such as intestinal obstructions or infertility. Adhesion prevention materials are used to keep tissues apart during the surgery and after, while tissues are healing. However, most existing adhesion prevention materials come in sheet form, which is difficult to use in narrow operating fields or laparoscopic surgery.

Healthcare is one of the growth drivers in the Teijin group's medium- to long-term management vision. The group plans to integrate its materials and healthcare technologies to facilitate its expansion into this business area.

About the Teijin Group

Teijin (TSE 3401) is a technology-driven global group offering advanced solutions in the areas of sustainable transportation, information and electronics, safety and protection, environment and energy, and healthcare. Its main fields of operation are high-performance fibers such as aramid, carbon fibers & composites, healthcare, films, resin & plastic processing, polyester fibers, products converting and IT. The group has some 150 companies and around 17,000 employees spread out over 20 countries worldwide. It posted consolidated sales of JPY745.7 billion (USD 7.4 billion) and total assets of JPY 762.4 billion (USD7.6 billion) in the fiscal year ending March 31, 2013. Please visit www.teijin.com .

Press Contact

Wenjie He

Corporate Communications

Teijin Limited

+81 3 3506 4055

pr@teijin.co.jp

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES